Sutro Biopharma, Inc. (STRO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook...
Source LinkSutro Biopharma, Inc. (STRO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook...
Source Link
Comments